Anthracycline-based adjuvant chemotherapy in early-stage uterine sarcomas: Long-term results of a single institution experience

European Journal of Gynaecological Oncology

Volumn 28, Issue 2, 2007, Pages 109-116

  Papadimitriou, C A ^a,b   Zorzou, M P ^a   Markaki, S ^a   Rodolakis, A ^a   Voulgaris, Z ^a   Bozas, G ^a   Kastritis, E ^a   Bamias, A ^a   Gika, D ^a   Dimopoulos, M A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Adjuvant chemotherapy; Anthracyclines; Early stage uterine sarcomas; Ifosfamide

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; METASTASIS; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PATIENT REFERRAL; PROBABILITY; PROGNOSIS; TREATMENT FAILURE; UTERUS SARCOMA;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FEMALE; HUMANS; IFOSFAMIDE; MIDDLE AGED; NEOPLASM STAGING; SARCOMA; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 34247881829     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Habib A., Vongtoma V., Kurohara S., Webster J.: "Radiotherapy in the treatment of sarcomas of the corpus uteri". Cancer, 1969, 24, 724.
2. Salazar O.M., Bonfiglio T.A., Patten S.F., Keller B.E., Feldstein M., Dunne M.E. et al.: "Uterine sarcomas: Natural history, treatment and prognosis". Cancer, 1978, 42, 1152.
3. Harlow B.L., Weiss N.S., Lofton S.: "The epidemiology of sarcomas of the uterus". J. Natl. Cancer Inst., 1986, 76, 399.
4. Malfetano J.H., Florentin R.: "Unusual tumors of the uterine corpus". In: Williams C.J., Krikorian J.G., Green M.R., Raghavan D. (eds.). Textbook of Uncommon Cancer. New York, John Wiley & Sons, Inc., 1988, 95.
5. DiSaia P.J., Creasman W.T.: "Sarcoma of the uterus". In: DiSaia P.J., Creasman W.T. (eds.). Clinical Gynecologic Oncology. St Louis, CV Mosby, 1989, 198.
6. Nordal P.R., Thoresen S.O.: "Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality". Eur. J. Cancer, 1997, 33, 907.
7. Brooks S.E., Zhan M., Cote T., Baquet C.R.: "Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999". Gynecol. Oncol., 2004, 93, 204.
8. Kempson R., Bari W.: "Uterine sarcomas: classification, diagnosis, and prognosis". Hum. Pathol., 1970, 1, 331.
9. George M., Pejovic M.H., Kramar A.: "Uterine sarcomas: prognostic factors and treatment modalities. Study on 209 patients". Gynecol. Oncol., 1986, 24, 58.
10. Major F.J., Blessing J.A., Silverberg S.G., Morrow C.P., Creasman W.T., Currie J.L. et al.: "Prognostic factors in early-stage uterine sarcoma: A Gynecologic Oncology Group study". Cancer, 1993, 71 (suppl.), 1702.
11. Bell S.W., Kempson R.L., Hendrickson M.R.: "Problematic uterine smooth muscle neoplasms: a clinicopathological study of 213 cases". Am. J. Surg. Pathol., 1994, 18, 535.
12. nd edition, New York, Lippincott-Raven Publishers, 1997, 897.
13. Olah K.S., Gee H., Blunt S., Dunn J.A., Kelly K., Chan K.K.: "Retrospective analysis of 318 cases of uterine sarcoma". Eur. J. Cancer, 1991, 27, 1095.
14. Goff B.A., Rice L.W., Fleischhacker D., Muntz H.G., Falkenberry S.S., Nikrui N., Fuller A.F. Jr.: "Uterine leiomyosarcoma and endometrial stromal sarcoma: Lymph node metastases and sites of recurrence". Gynecol. Oncol., 1993, 50, 105.
15. Lennart K., Lennart B., Ulf S., Bernard T.: "Flow cytometric analysis of uterine sarcomas". Gynecol. Oncol., 1994, 55, 339.
16. Wolfson A.H., Wolfson D.J., Sittler S.Y., Breton L., Markoe A.M., Schwade J.G. et al.: "A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas". Gynecol. Oncol., 1994, 52, 56.
17. Nordal R.P., Kristensen G.B., Kaern J., Stenwig A.E., Pettersen E.O., Trope C.G.: "The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma". Gynecol. Oncol., 1996, 62, 254.
18. Pautier P., Genestie C., Rey A., Morice P., Roche B., Lhomme C., et al.: "Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma". Cancer, 2000, 88, 1425.
19. Gerszten K., Faul C., Kounelis S., Huang Q., Kelley J., Jones M.W.: "The impact of adjuvant radiotherapy on carcinosarcoma of the uterus". Gynecol. Oncol., 1998, 68, 8.
20. Hoffmann W., Schmandt S., Kortmann R.D., Schiebe M., Dietl J., Bamberg M.: "Radiotherapy in the treatment of uterine sarcomas. A retrospective analysis of 54 cases". Gynecol. Obstet. Invest., 1996, 42, 49.
21. Gadducci A., Sartoni E., Landoni F., Zola P., Maggino T., Urgesi A. et al.: "Endometrial stromal sarcoma : Analysis of treatment failures and survival". Gynecol. Oncol., 1996, 63, 247.
22. Weitmann H.D., Knocke T.H., Kucera H., Potter R.: "Radiation therapy in the treatment of endometrial stromal sarcoma". Int. J. Radiat. Oncol. Phys., 2001, 49, 739.
23. Berchuck A., Rubin S.C., Hoskins W.J., Saigo P.E., Pierce V.K., Lewis J.L. Jr.: "Treatment of endometrial stromal tumors". Gynecol. Oncol., 1990, 36, 60.
24. Rose P.G., Boutselis J.G., Sachs L.: "Adjuvant therapy for Stage I uterine sarcoma". Am. J. Obstet. Gynecol., 1987, 156, 660.
25. Giuntoli R.L., Metzinger D.S., DiMarco C.S., Cha S.S., Sloan J.A., Keeney G.L., Gostout B.S.: "Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy". Gynecol. Oncol., 2003, 89, 460.
26. Omura G.A., Blessing J.A., Major F., Lifshitz S., Ehrlich C.E., Mangan C. et al.: "A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: A Gynecologic Oncology Group Study". J. Clin. Oncol., 1985, 3, 1240.
27. Berchuck A., Rubin S.C., Hoskins W.J., Saigo P., Pierce V.K., Lewis J.L. Jr.: "Treatment of uterine leiomyosarcoma". Obstet. Gynecol., 1988, 71, 845.
28. Kaplan E., Meier F.: "Non-parametric estimation from incomplete observations". J. Am. Stat. Assoc., 1958, 58, 457.
29. Nordal R.P., Kristensen G.B., Stenwig A.E., Nesland J.M., Petersen E.O., Trope C.G.: "An evaluation of prognostic factors in uterine carcinosarcoma". Gynecol. Oncol., 1997, 67, 316.
30. Blom R., Guerrieri C., Stal O., Malmstrom H., Simonsen E.: "Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases". Gynecol. Oncol., 1998, 68, 54.
31. Mayerhofer K., Obermair A., Windbichler G., Petru E., Kaider A., Hefler L. et al.: "Leiomyosarcoma of the uterus: A clinicopathologic multicenter study of 71 cases". Gynecol. Oncol., 1999, 74, 196.
32. Bodner K., Bodner-Adler B., Obermair A., Windbichler G., Petru E., Mayerhofer S. et al.: "Prognostic parameters in endometrial stromal sarcoma: A clinicopathologic study in 31 patients". Gynecol. Oncol., 2001, 81, 160.
33. Moskovic E., McSweeney E., Law M., Price A.: "Survival, patterns of spread and prognostic factors in uterine sarcoma: A study of 76 patients". Br. J. Radiol., 1993, 66, 1009.
34. Chauveinc L., Deniaud E., Plancher C., Sastre X., Amsani F., de la Rochefordiere A. et al.: "Uterine sarcomas: The Curie Institute experience. Prognostic factors and adjuvant treatments". Gynecol. Oncol., 1999, 72, 232.
35. Yamada S.D., Burger R.A., Brewster W.R., Anton D., Kohler M.F., Monk B.J.: "Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinocarcoma of the uterus". Cancer, 2000, 88, 2782.
36. Knocke T.H., Kucera H., Dorfler D., Pokrajac B., Potter R.: "Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri". Cancer, 1998, 83, 1972.
37. Hornback N.B., Omura G., Major F.J.: "Observations on the use of adjuvant radiation therapy in patients with Stage I and II uterine sarcoma". Int. J. Radiat. Oncol. Biol. Phys., 1986, 12, 2127.
38. Larson B., Silfversward C., Nilsson B., Pettersson F.: "Mixed mullerian tumours of the uterus-prognostic factors: A clinical and histopathologic study of 147 cases". Radiother. Oncol., 1990, 17, 123.
39. Chi D.S., Mychalczak B., Saigo P.E., Rescigno J., Brown C.L.: "The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma". Gynecol. Oncol., 1997, 65, 493.
40. Knocke T.H., Weitmann H.D., Kucera H., Kolbl H., Pokrajac B., Potter R.: "Results of primary and adjuvant radiotherapy in the treatment of mixed mullerian tumors of the corpus uteri". Gynecol. Oncol., 1999, 73, 389.
41. Echt G., Jepson J., Steel J., Langholz B., Luxton G., Hernandez W., Astrahan M., Petrovich Z.: "Treatment of uterine sarcomas". Cancer, 1990, 66, 35.
42. Gadducci A., Landoni F., Sartori E., Zola P., Maggino T., Lissoni A. et al.: "Uterine leiomyosarcoma: Analysis of treatment failures and survival". Gynecol. Oncol., 1996, 62, 25.
43. Dinh T.A., Oliva E.A., Fuller A.F. Jr., Lee H., Goodman A.: "The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital". Gynecol. Oncol., 2004, 92, 648.
44. Bramwell V., Rouesse J., Steward W., Santoro A., Schraffordt-Koops H., Buessa J. et al.: "Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: A study of the European Organization for Research and Treatment of Cancer soft tissue and bone sarcoma group". J. Clin. Oncol., 1994, 12, 1137.
45. Frustaci S., Gherlinzoni F., De Paoli A., Bonetti M., Azzarelli A., Comandone A. et al.: "Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial". J. Clin. Oncol., 2001, 19, 1238.
46. Tierney J.: "Adjuvant chemotherapy for localized resectable soft tissue sarcoma of adults". In: The Cochrane Database of Systemic Reviews. Oxford: The Cochrane Library, 1999, 2, 1.
47. Buchsbaum H.J., Lifshitz S., Blythe J.G.: "Prophylactic chemotherapy in Stages I and II uterine sarcoma". Gynecol. Oncol., 1979, 8, 346.
48. Hannigan E.V., Freedman R.S., Rutledge F.N.: "Adjuvant chemotherapy in early uterine sarcoma". Gynecol. Oncol., 1983, 15, 56.
49. Van Nagell J.R. Jr, Hanson M.B., Donaldson E.S., Gallion H.H.: "Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in Stage I uterine sarcomas. A pilot study". Cancer, 1986, 57, 1451.
50. Odunsi K., Moneke V., Tammela J., Ghamande S., Seago P., Driscoll D. et al.: "Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: Results of long-term follow-up". Int. J. Gynecol. Cancer, 2004, 14, 659.
51. Kushner D.M., Webster K.D., Belinson J.L., Rybicki L.A., Kennedy A.W., Markman M.: "Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma". Gynecol. Oncol., 2000, 78, 221.
52. Pautier P., Rey A., Haie-Meder C., Kerbrat P., Dutel J.L., Gesta P. et al.: "Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: Results of a case-control study with radiotherapy alone". Int. J. Gynecol. Cancer, 2004, 14, 1112.
53. Sutton G., Kauderer J., Carson L.F., Lentz S.S., Whitney C.W., Gallion H.: "Adjuvant ifosfamide and cisplatin in patients with completely resected Stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: A Gynecologic Oncology Group Study". Gynecol. Oncol., 2005, 96, 630.
54. McCluggage W.G.: "Uterine carcinosarcomas are metaplastic carcinomas". Int. J. Gynecol. Cancer, 2002, 12, 687.
55. Sutton G.P., Blessing J.A., Rosenshein N., Photopulos G., DiSaia P.J.: "Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group Study)". Am. J. Obstet. Gynecol., 1989, 161, 309.
56. Sutton G.P., Bleesing J.A., Barrett R.J., McGehee R.: "Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: A Gynecologic Oncology Group Study". Am. J. Obstet. Gynecol., 1992, 166, 556.
57. Sutton G., Blessing J.A., Malfetano J.H.: "Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: A Gynecologic Oncology Group Study". Gynecol. Oncol., 1996, 62, 226.
58. Sutton G., Brunetto V.L., Kilgore L., Soper J.T., McGehee R., Olt G. et al.: "A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study". Gynecol. Oncol., 2000, 79, 147.
59. Piver M.S., Lele S.B., Marchetti D.L., Emrich L.J.: "Effect of adjuvant chemotherapy on time to recurrence and survival of Stage I uterine sarcomas". J. Surg. Oncol., 1988, 38, 233.
60. Hempling R.E., Piver M.S., Baker T.R.: "Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for Stage I uterine sarcoma. A prospective trial". Am. J. Clin. Oncol., 1995, 18, 282.
61. Resnik E., Chambers S.K., Carcangiu M.L., Kohorn E.I., Schwartz P.E., Chambers J.T.: "A phase II study of etoposide, cisplatin and doxorubicin chemotherapy in mixed mullerian tumors (MMT) of the uterus". Gynecol. Oncol., 1995, 56, 370.
62. Sartori E., Bazzurini L., Gadducci A., Landoni F., Lissoni A., Maggino T. et al.: "Carcinosarcoma of the uterus: A clinicopathological multicenter CTF study". Gynecol. Oncol., 1997, 67, 70.